NCT05910463

Brief Summary

An evaluation study of the impact of the Axomove Therapy® medical device on subacute or chronic low back pain patients leaving rehabilitation centres to facilitate self-rehabilitation. A prospective, randomized, open-label, multicentre study whose main objective is to evaluate the effectiveness of the Axomove Therapy Medical Device on disability reduction (Oswestry disability index score) patients with subacute or chronic low back pain requiring rehabilitation.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
190

participants targeted

Target at P75+ for not_applicable low-back-pain

Timeline
Completed

Started Jun 2023

Typical duration for not_applicable low-back-pain

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 5, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

June 18, 2023

Completed
10 days until next milestone

Study Start

First participant enrolled

June 28, 2023

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2024

Completed
Last Updated

July 21, 2023

Status Verified

April 1, 2023

Enrollment Period

1.2 years

First QC Date

April 5, 2023

Last Update Submit

July 19, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Efficacy of AXOMOVE Therapy

    Functional capacity of patients measured through the Oswestry Disability Index score

    14 weeks (105 days)

Secondary Outcomes (4)

  • Level of patient physical activity

    day 0 (inclusion), day 15, day 45 and day 105

  • Quality of life

    day 0 (inclusion), day 15, day 45 and day 105

  • Quality of life

    day 0 (inclusion), day 15, day 45 and day 105

  • Efficacy of AXOMOVE Therapy

    day 0 (inclusion), day 15, day 45

Study Arms (2)

AXOMOVE Therapy

EXPERIMENTAL

Use of a web and mobile application for remote monitoring and rehabilitation

Other: AXOMOVE Therapy Medical Device

Routine care

NO INTERVENTION

Current rehabilitation support care

Interventions

Personalized exercise programs for the self-rehabilitation of low back pain patients

AXOMOVE Therapy

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient aged 18-65 years,
  • Patient agreeing to install the Axomove Therapy® application and agreeing to follow the study protocol,
  • Patient with physical, sensory and cognitive ability to use an application (digital tools) on a smartphone, tablet or computer and perform physical exercise programs,
  • A patient who is a member of, or in receipt of, a social security scheme.

You may not qualify if:

  • Patients who are unable to understand, read or speak French,
  • Inability to receive informed information,
  • A patient with a sensory, visual or tactile impairment that prevents the correct use of a smartphone, tablet and/or computer, or prevents the exercise from being carried out safely,
  • Patient with suspected or proven serious pathology such as recent vertebral fractures (less than 6 months), infection, malignant tumors and/or radiculopathy,
  • Patient with a history of rheumatic inflammatory disease,
  • Patient with true radiculalgia,
  • Patient with scoliosis \> 30°, Patient with lumbar surgery in the past 12 months,
  • Pregnant patient, parturient or breastfeeding,
  • Patient under legal protection (guardianship, curatorship),
  • A patient with a serious and/or uncontrolled illness that, in the opinion of the investigator, could result in unacceptable safety risks or compromise protocol compliance, for example: an active or uncontrolled infection.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHRU de LILLE

Lille, 59000, France

RECRUITING

MeSH Terms

Conditions

Low Back Pain

Condition Hierarchy (Ancestors)

Back PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Valerie WIECZOREK, MD

    CHU de Lille

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 5, 2023

First Posted

June 18, 2023

Study Start

June 28, 2023

Primary Completion

September 1, 2024

Study Completion

September 1, 2024

Last Updated

July 21, 2023

Record last verified: 2023-04

Data Sharing

IPD Sharing
Will not share

Locations